financetom
Business
financetom
/
Business
/
Sunrun Stock Soars Over 30% After Surprise Q2 Profit and Record Storage Growth
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sunrun Stock Soars Over 30% After Surprise Q2 Profit and Record Storage Growth
Aug 7, 2025 12:06 PM

Sunrun Inc. ( RUN ) shares surged more than 30% Thursday after the company reported second-quarter financial results.

What To Know: The company posted earnings of $1.07 per share, beating estimates of a loss of 18 cents per share. Revenue reached $569.33 million, exceeding the expected $548.4 million and rising from $523.86 million in the same quarter last year.

Operationally, Sunrun ( RUN ) added 28,823 new subscribers in the second quarter, representing a 15% increase year-over-year. Total subscribers reached 941,701 by the end of June, reflecting 14% annual growth. Solar capacity installed rose to 227 megawatts, up 18% from the prior year, while storage capacity installed jumped 48% to 392 megawatt hours. Subscriber value and contracted subscriber value also increased significantly, up 22% and 19% respectively.

CEO Mary Powell highlighted that Sunrun ( RUN ) achieved a new record for Contracted Net Value Creation, with a 70% storage attachment rate, the highest in company history. She attributed the performance to disciplined growth, cost improvements, and increasing generation capabilities.

Following Sunrun's ( RUN ) strong second-quarter results, analysts have begun to raise their price targets on the stock. Susquehanna analyst Biju Perincheril maintained a Positive rating on Sunrun ( RUN ) and increased the price target from $12 to $13. Similarly, Oppenheimer analyst Colin Rusch reiterated an Outperform rating and lifted the price target from $20 to $21.

RUN Price Action: Sunrun ( RUN ) shares were up 30.3% at $11.82 at the time of writing, according to Benzinga Pro.

Read Next:

Apple’s Smart Move May Save iPhone Sales–And The Stock Could Soar

Image Via Shutterstock.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ACM Research Q4 Non-GAAP Earnings, Revenue Rise
ACM Research Q4 Non-GAAP Earnings, Revenue Rise
Feb 26, 2025
05:49 AM EST, 02/26/2025 (MT Newswires) -- ACM Research ( ACMR ) reported Q4 non-GAAP earnings Wednesday of $0.56 per diluted share, up from $0.43 a year earlier. Four analysts polled by FactSet expected $0.39. Revenue for the quarter ended Dec. 31 was $223.5 million, up from $170.3 million a year earlier. Analysts surveyed by FactSet expected $194.9 million. For...
Update: QXO Extends Tender Offer Period to Acquire Beacon Roofing Supply
Update: QXO Extends Tender Offer Period to Acquire Beacon Roofing Supply
Feb 26, 2025
05:47 AM EST, 02/26/2025 (MT Newswires) -- (Updates with QXO's response in the fourth paragraph and latest stock movement in the fifth paragraph.) QXO (QXO) said Tuesday that its all-cash tender offer to acquire all outstanding Beacon Roofing Supply's ( BECN ) shares for $124.25 apiece will now expire on Monday, March 3, at 5 p.m. ET, rather than Feb....
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Feb 26, 2025
Feb 26 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1030 GMT on Wednesday: ** Switzerland-based pesticides maker Syngenta said that it has acquired a repository of natural compounds and genetic strains from drugmaker Novartis to further boost the development of biologic crop protection. ** Italian lender UniCredit has reported its planned acquisition of a 29.99%...
BridgeBio Pharma Prices $500 Million Convertible Senior Notes Offering
BridgeBio Pharma Prices $500 Million Convertible Senior Notes Offering
Feb 26, 2025
05:52 AM EST, 02/26/2025 (MT Newswires) -- BridgeBio Pharma ( BBIO ) said Wednesday it priced $500 million of 1.75% convertible senior notes due March 1, 2031 in a private offering, for about $489.5 million in expected net proceeds. The company granted the initial purchasers an option to buy up to an additional $75 million of notes. BridgeBio said it...
Copyright 2023-2026 - www.financetom.com All Rights Reserved